Bristol-Myers Squibb

Bristol, Merck, Roche immune therapies are cancer meeting focus
Yahoo/Reuters
Thu, 05/15/14 - 08:24 am
Bristol-Myers Squibb
Merck
Roche
ASCO
cancer
anti-PD-1 immunotherapy
Bristol, Celldex Collaborating on Cancer Immunotherapy Study
TheStreet.com
Wed, 05/14/14 - 09:10 am
cancer immunotherapy
Celldex
Bristol-Myers Squibb
[video]ASCO Abstracts: Bristol-Myers Squibb's and Merck's Immuno-Oncology Drugs
Motley Fool
Wed, 05/14/14 - 08:22 am
ASCO
Bristol-Myers Squibb
Merck
immuno-oncology
Show me the money: Which drugs made the top 10 list on upfront deals?
Fierce Biotech
Mon, 05/12/14 - 09:36 am
biotech
GED-0301
Celgene
Nogra Pharma
AbbVie
Reata
Bardoxolone
Abbott Labs
Tradjenta
Eli Lilly
Boehringer Ingelheim
FG-4592
AstraZeneca
FibroGen
Pfizer
Bristol-Myers Squibb
Eliquis
Moderna
Forma Therapeutics
dimebon
Medivation
Jakafi
Novartis
Incyte
Bristol-Myers: Nivolumab Holds Good Potential
Seeking Alpha
Mon, 05/12/14 - 08:12 am
nivolumab
Bristol-Myers Squibb
Can Bristol-Myers Squibb Make a Comeback in 2014?
Motley Fool
Tue, 05/6/14 - 04:38 pm
Bristol-Myers Squibb
Bristol-Myers' armed antibody partner Ambrx shoots for an $86M IPO
Fierce Biotech
Mon, 05/5/14 - 05:15 pm
IPOs
Bristol-Myers Squibb
Ambrx
Why Merck Is Still A Big Pharma Kingpin
Seeking Alpha
Mon, 05/5/14 - 08:26 am
Merck
Bristol-Myers Squibb
Gilead Sciences
Roche
MK-3475
hepatitis C
New Melanoma Therapies Are Ready For Primetime: Sanjiv Agarwala
Seeking Alpha
Wed, 04/30/14 - 12:50 pm
melanoma
Bristol-Myers Squibb
Roche
Merck
Amgen
6 Drugs That Could Move the Pharma Market
Wall St Cheat Sheet
Wed, 04/30/14 - 12:37 pm
Gilead Sciences
Teva Pharmaceuticals
Copaxone
Idelalisib
Bristol-Myers Squibb
nivolumab
Cyramza
Eli Lilly
Pfizer
palbociclib
Sovaldi
Bristol-Myers racing to the FDA with immunotherapy star nivolumab
Fierce Biotech
Tue, 04/29/14 - 10:05 am
FDA
immunotherapy
nivolumab
Bristol-Myers Squibb
Bristol-Myers quarterly profit beats expectations as costs cut
Yahoo/Reuters
Tue, 04/29/14 - 08:11 am
Bristol-Myers Squibb
earnings
Bristol-Myers Squibb Acquires iPierian, Inc.
Yahoo
Tue, 04/29/14 - 08:10 am
iPierian
Bristol-Myers Squibb
M&A
IPN007
Will Bristol-Myers (BMY) Beat Q1 Earnings?
Yahoo/Zacks.com
Mon, 04/28/14 - 05:52 pm
earnings
Bristol-Myers Squibb
Say Hello to 3 Existing and Upcoming Next-Generation Blockbuster Drugs
Motley Fool
Sun, 04/27/14 - 09:51 am
Sovaldi
Gilead Sciences
Imbruvica
Pharmacyclics
JNJ
Eliquis
Bristol-Myers Squibb
Pfizer
Drug innovation: In the recovery room
FT.com
Fri, 04/25/14 - 03:21 pm
innovation
Roche
Novartis
GSK
Merck
Bristol-Myers Squibb
BMS extends deal with Samsung as its pipeline percolates with more biologics
Fierce Pharma
Fri, 04/25/14 - 09:08 am
Bristol-Myers Squibb
Samsung BioLogics
Pfizer, AstraZeneca Are Ripe for Pharma Deal Alone or Together
Yahoo/Bloomberg
Tue, 04/22/14 - 10:07 am
Pfizer
AstraZeneca
M&A
Bristol-Myers Squibb
Shire
Amgen
AbbVie
Success Of Rexahn's Nano-Sized Taxotere Can Help Big Pharma Ease Patent Cliff
Seeking Alpha
Mon, 04/21/14 - 04:46 pm
Taxotere
Rexahn
RX-21101
patents
patent cliff
Bristol-Myers Squibb
Roche
Sanofi
Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides
Motley Fool
Thu, 04/17/14 - 11:49 am
Sovaldi
hepatitis C
Gilead Sciences
AbbVie
Merck
Bristol-Myers Squibb
Express Scripts

Pages